$REFG showing some pre-market life, broke resistance, but imo needs to hold above that after the market opens. They are supporting the U.S. Food and Drug Administration’s (FDA) decision to grant orphan drug designation for a cannabis extract for use in children with a severe form of epilepsy called Dravet syndrome.
(0)
(0)